Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.13
+0.03 (0.59%)
Jun 9, 2025, 4:08 PM HKT

Lepu Biopharma Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Revenue
367.79225.3515.57--
Upgrade
Revenue Growth (YoY)
63.21%1347.16%---
Upgrade
Cost of Revenue
74.8228.282.01--
Upgrade
Gross Profit
292.97197.0813.57--
Upgrade
Selling, General & Admin
237.89129.95140.58156.2493.76
Upgrade
Research & Development
437.7458.07524.29791.21354.43
Upgrade
Other Operating Expenses
13.23-0.38-8.85-3.77-0.73
Upgrade
Operating Expenses
688.82587.65656.02943.68447.45
Upgrade
Operating Income
-395.85-390.57-642.45-943.68-447.45
Upgrade
Interest Expense
-21.65-14.68-7.47-2.7-85.21
Upgrade
Interest & Investment Income
4.678.188.359.110.36
Upgrade
Earnings From Equity Investments
-16.44-27.34-32.23-17.7-12.08
Upgrade
Currency Exchange Gain (Loss)
1.330.2137.75-2.410.04
Upgrade
Other Non Operating Income (Expenses)
3.74173.64-64-76.86-1.11
Upgrade
EBT Excluding Unusual Items
-424.2-250.56-700.05-1,034-535.46
Upgrade
Gain (Loss) on Sale of Investments
-220.26-5.37-77.99
Upgrade
Gain (Loss) on Sale of Assets
0.01-0.61--
Upgrade
Pretax Income
-424.19-30.3-699.44-1,029-613.45
Upgrade
Earnings From Continuing Operations
-424.19-30.3-699.44-1,029-613.45
Upgrade
Minority Interest in Earnings
12.828.2110.3917.8731.6
Upgrade
Net Income
-411.38-22.1-689.05-1,011-581.85
Upgrade
Net Income to Common
-411.38-22.1-689.05-1,011-581.85
Upgrade
Shares Outstanding (Basic)
1,6901,6591,6411,5201,135
Upgrade
Shares Outstanding (Diluted)
1,6901,6591,6411,5201,135
Upgrade
Shares Change (YoY)
1.87%1.14%7.92%33.97%74.89%
Upgrade
EPS (Basic)
-0.24-0.01-0.42-0.66-0.51
Upgrade
EPS (Diluted)
-0.24-0.01-0.42-0.66-0.51
Upgrade
Free Cash Flow
-229.31-278.84-591.38-835.12-661.95
Upgrade
Free Cash Flow Per Share
-0.14-0.17-0.36-0.55-0.58
Upgrade
Gross Margin
79.66%87.45%87.12%--
Upgrade
Operating Margin
-107.63%-173.32%-4125.67%--
Upgrade
Profit Margin
-111.85%-9.80%-4424.94%--
Upgrade
Free Cash Flow Margin
-62.35%-123.73%-3797.71%--
Upgrade
EBITDA
-313.69-306.66-564.63-866.49-383.76
Upgrade
EBITDA Margin
-85.29%-136.08%---
Upgrade
D&A For EBITDA
82.1683.9177.8277.1863.69
Upgrade
EBIT
-395.85-390.57-642.45-943.68-447.45
Upgrade
EBIT Margin
-107.63%-173.31%---
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.